Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-745bb68f8f-b95js Total loading time: 0 Render date: 2025-01-12T11:18:48.029Z Has data issue: false hasContentIssue false

Epstein–Barr virus infection

from Medical topics

Published online by Cambridge University Press:  18 December 2014

By
Rona Moss-Morris  and
Meagan Spence
Edited by
Susan Ayers ,
Andrew Baum ,
Chris McManus ,
Stanton Newman ,
Kenneth Wallston ,
John Weinman  and
Robert West
Rona Moss-Morris
Affiliation:
University of Southampton
Meagan Spence
Affiliation:
The University of Auckland
Susan Ayers
Affiliation:
University of Sussex
Andrew Baum
Affiliation:
University of Pittsburgh
Chris McManus
Affiliation:
St Mary's Hospital Medical School
Stanton Newman
Affiliation:
University College and Middlesex School of Medicine
Kenneth Wallston
Affiliation:
Vanderbilt University School of Nursing
John Weinman
Affiliation:
United Medical and Dental Schools of Guy's and St Thomas's
Robert West
Affiliation:
St George's Hospital Medical School, University of London
Get access

Summary

The Epstein–Barr virus (EBV) is a tumourogenic herpes virus that has been implicated in a wide range of human illnesses such as Hodgkin's disease and B lymphoproliferative disease; however it most commonly causes infectious mononucleosis (IM) often referred to as glandular fever (Macsween & Crawford, 2003). Primary infection with EBV typically occurs subclinically between the ages of one and six, after which the virus latently inhabits B lymphocyte cells. Previous infection with EBV is indicated by the presence of EBV antibody titres in the serum, while lack of these antibodies indicates vulnerability to EBV infection (Kasl et al., 1979). In the Western world, a second peak of EBV infection occurs between 14 and 20 years of age. Estimates suggest that 90% of the world's population are seropositive for EBV by the age of 30 and carry the virus as a lifelong latent infection (Papesch and Watkins, 2001).

Epstein–Barr virus and infectious mononucleosis

When people get infected with EBV, a number seroconvert without developing the clinical signs of IM. Those who develop the clinical syndrome experience an acute illness characterized by fatigue, sore throat, tender lymph nodes and fever, which usually resolves within two to four weeks (Rea et al., 2001). The puzzle is why some infected individuals develop clinical IM while others do not.

In an attempt to answer this question, Kasl and colleagues (1979) investigated 432 young American cadets over a four-year period.

Type
Chapter
Information
Cambridge Handbook of Psychology, Health and Medicine , pp. 705 - 707
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Buchwald, D. & Komaroff, A. L. (1991). Review of laboratory findings for patients with chronic fatigue syndrome. Reviews of Infectious Disease, 13, S12–18.Google Scholar
Buchwald, D. S., Rea, T. D., Katon, W. J., Russo, J. E. & Ashley, R. L. (2000). Acute infectious mononucleosis: characteristics of patients who report failure to recover. American Journal of Medicine, 109, 531–7.Google Scholar
Burleson, M. H., Poehlmann, K. M., Hawkley, L.C.et al. (2002). Stress-related immune changes in middle-aged and older women: 1-year consistency of individual differences. Health Psychology, 21, 321–31.Google Scholar
Candy, B., Chalder, T., Cleare, A. J.et al. (2003). Predictors of fatigue following the onset of infectious mononucleosis. Psychological Medicine, 33, 847–55.Google Scholar
Candy, B., Chalder, T., Cleare, A. J., Wessely, S. & Hotopf, M. (2004). A randomised controlled trial of a psycho-educational intervention to aid recovery in infectious mononucleosis. Journal of Psychosomatic Research, 57, 89–94.Google Scholar
Esterling, B. A., Antoni, M. H., Kumar, M. & Schneiderman, N. (1993). Defensiveness, trait anxiety, and Epstein–Barr viral capsid antigen antibody titers in healthy college students. Health Psychology, 12, 132–9.Google Scholar
Glaser, R., Friedman, S. B., Smyth, J.et al. (1999). The differential impact of training stress and final examination stress on herpes virus latency at the United States Military Academy at West Point. Brain, Behavior, & Immunity, 13, 240–51.Google Scholar
Kasl, S. V., Evans, A. & Niederman, J. C. (1979). Psychosocial risk factors in the development of infectious mononucleosis. Psychosomatic Medicine, 41, 445–66.Google Scholar
Katon, W., Russo, J. E., Ashley, R. L. & Buchwald, D.S. (1999). Infectious mononucleosis: psychological symptoms during the acute and subacute phases of illness. General Hospital Psychiatry, 21, 21–9.Google Scholar
Kiecolt-Glaser, J. K., Kennedy, S., Malkoff, S.et al. (1988). Marital discord and immunity in males. Psychosomatic Medicine, 50, 213–29.Google Scholar
Macsween, K. F. & Crawford, D.H. (2003). Epstein–Barr virus – recent advances. The Lancet Infectious Diseases, 3, 131–40.Google Scholar
Matthews, D. A., Lane, T. J. & Manu, P. (1991). Antibodies to Epstein–Barr virus in patients with chronic fatigue. Southern Medical Journal, 84, 832–40.Google Scholar
Moss-Morris, R. & Petrie, K. (2000). Chronic fatigue syndrome, London: Routledge.
Papesch, M. & Watkins, R. (2001). Epstein–Barr virus infectious mononucleosis. Clinical Otolaryngology and Allied Sciences, 26, 3–8.Google Scholar
Rea, T., Russo, J., Katon, W., Ashley, R.L. & Buchwald, D. (1999). A prospective study of tender points and fibromyalgia during and after an acute viral infection. Archives of Internal Medicine, 159, 865–70.Google Scholar
Rea, T. D., Russo, J. E., Katon, W., Ashley, R.L. & Buchwald, D.S. (2001). Prospective study of the natural history of infectious mononucleosis caused by Epstein–Barr virus. Journal of the American Board of Family Practice, 14, 234–42.Google Scholar
Sarid, O., Anson, O., Yaari, A. & Margalith, M. (2001). Epstein–Barr virus specific salivary antibodies as related to stress caused by examinations. Journal of Medical Virology, 64, 149–56.Google Scholar
Spence, M. & Moss-Morris, R. (in preparation). The path from glandular fever to chronic fatigue syndrome: can the cognitive behavioural model provide map?
Stowe, R. P., Pierson, D. L. & Barrett, A. D. (2001). Elevated stress hormone levels relate to Epstein–Barr virus reactivation in astronauts. Psychosomatic Medicine, 63, 891–5.Google Scholar
Surawy, C., Hackmann, A., Hawton, K. & Sharpe, M. (1995). Chronic fatigue syndrome: a cognitive approach. Behaviour Research Therapy, 33, 535–44.Google Scholar
Rood, Y. R., Bogaards, M., Goulmy, E. & Houwelingen, H.C. (1993). The effects of stress and relaxation on the in vitro immune response in man: a meta-analytic study. Journal of Behavioural Medicine, 16, 163–81.Google Scholar
White, P. D., Thomas, J. M., Amess, J.et al. (1998). Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. British Journal of Psychiatry, 173, 475–81.Google Scholar
White, P. D., Thomas, J. M., Kangro, H. O.et al. (2001). Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis. Lancet, 358, 1946–54.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×